Solara Active Pharma Sciences logo

Solara Active Pharma Sciences results

NSE: SOLARABSE: 541540Pharmaceuticals & BiotechnologySmall Cap

Last close ₹611.55down ₹7.50 (1.21%)BSE ₹612.20

Share price at the NSE close on 23 Oct 2026. Previous close ₹619.05.

52-week range of traded prices to 23 Oct 2026
₹422.00Low, 30 Mar 2026₹774.00High, 15 Sep 2026
Market cap
₹2,951 Cr1,182nd largest listed
P/E
79.9
P/E without one-offs
62.3
P/B
2.1
Dividend yield
Nonein the last 12 months
ROE
2.7%
ROE without one-offs
3.5%
ROCE
6.4%
Debt to equity
0.40
Volume, NSE
5,34,15343.0% delivered

Q2 results, quarter to Sep 2026

Consolidated: the company and its subsidiaries together. ₹ crore.Solara Active Pharma Sciences annual results and balance sheet

Revenue
₹417 Cr+33.1% on a year ago · +9.4% on the quarter before
Operating profit
₹77 Cr+121.2% on a year ago · +24.0% on the quarter before
Net profit
₹28 Cr+74.5% on the quarter before
Earnings per share
₹5.92+68.2% on the quarter before
Operating margin
18.4%
Net margin
6.8%

From revenue to net profit, ₹ crore

  1. Revenue417
  2. Materials and goods−214
  3. Employee costs−58
  4. Other expenses−69
  5. Operating profit77
  6. Depreciation−27
  7. Other income+0.5
  8. One-off items−4.5
  9. Finance costs−18
  10. Profit before tax28
  11. Tax0.0
  12. Net profit28

Solara Active Pharma Sciences results by quarter

Consolidated: the company and its subsidiaries together. Latest quarter to Sep 2026. Results for the quarter to Dec 2026 are due by 14 Feb 2027, 45 days after it ends.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreDec 2021Q3Filed 9 FebMar 2022Q4Filed 30 AprJun 2022Q1Filed 5 AugSep 2022Q2Filed 10 NovDec 2022Q3Filed 25 JanMar 2023Q4Filed 13 MayJun 2023Q1Filed 14 AugSep 2023Q2Filed 24 NovDec 2023Q3Filed 26 FebMar 2024Q4Filed 19 JulJun 2024Q1Filed 30 AugSep 2024Q2Filed 4 NovDec 2024Q3Filed 24 JanMar 2025Q4Filed 10 JunJun 2025Q1Filed 25 JulSep 2025Q2Filed 6 NovDec 2025Q3Filed 6 FebMar 2026Q4Filed 15 MayJun 2026Q1Filed 23 JulSep 2026Q2Filed 16 Oct
Revenue from operations100361330338395381352425249299363347300273319314349387382417
197347318311350332333388410290322286243228262279312330320341
Materials and goods bought54234196189211192192238216160202172135118146154187197196214
Employee costs6644545658606164635655535252545555555658
Other expenses78696865807980861327465615657627070776769
Operating profit before depreciation−9714132845491938−1621042615845573537586277
Operating margin−96.5%3.7%3.8%8.1%11.4%12.8%5.4%8.8%−65.0%3.3%11.5%17.7%19.2%16.6%17.9%11.1%10.7%14.9%16.2%18.4%
Depreciation and amortisation2828282928262626262525252524242426262727
Other income56747521021016100531
Finance costs1821232224222524253131282729242122282218
Profit before one-off items and tax−138−30−31−1915−29−12−213−44−1388−211−10−1191633
One-off items−2−100000−5−63−122000000−710−5
Profit before tax−140−31−31−1915−29−17−275−167−1388−211−10−17101628
0−33−15−901−1000890000000000
Tax rate––––21.8%25.4%–––––0.0%0.0%–0.0%––0.0%0.0%0.0%
−1402−16−1004−19−17−275−255−1388−211−10−17101628
Other comprehensive income020−10−10000020−1012100
Total comprehensive income−1403−17−1103−19−17−275−255−13108−311−9−16101629
Net margin−139.4%0.5%−5.0%−2.9%0.1%1.0%−5.4%−4.0%−110.7%−85.3%−3.7%2.3%2.7%−0.8%3.3%−3.2%−5.0%2.5%4.3%6.8%
Earnings per share−₹38.93₹0.53−₹4.56−₹2.77₹0.12₹1.05−₹5.43−₹4.77−₹76.49−₹70.93−₹3.50₹2.54₹2.03−₹0.93₹2.46−₹2.36−₹3.98₹2.20₹3.52₹5.92
Earnings per share in rupees, restated for later splits and bonuses.

The quarters either side of a change of basis do not compare. From the quarter to Mar 2024, the company's revenue for the year to Mar 2024, ₹1,289 Cr, differs from its quarters added, ₹1,326 Cr.

Filed results, as an XML file each

16 earlier filings